Journal article · 2023

Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy

Qi He, Liming Zhou, D.P. Yu, Ren Zhu, Yue Chen, Mingbo Song, Xintong Liu, Yixian Liao, Tong Ding, Wenpei Fan, Wenying Yu

Journal of Medicinal Chemistry, 66(15), 10458–10472 · Published 6 June 2023 · DOI 10.1021/acs.jmedchem.3c00587

View at the publisherCite this paper

In brief

“Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy” is a 2023 journal article by Qi He and 10 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 88 citations as of 21 November 2026, which puts it in the top 3% of works published in 2023 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
88
Most cited in
2026 (40)
Field-weighted impact
6.18
References
49
Authors
11

Abstract

As a novel protein knockdown tool, proteolysis targeting chimeras (PROTACs) can induce potent degradation of target proteins by hijacking E3 ubiquitin ligases. However, the uncontrollable protein disruption of PROTACs is prone to cause “off-target” toxicity after systemic administration. Herein, we designed a photocaged-PROTAC (phoBET1) and loaded it in UCNPs-based mesoporous silica nanoparticles (UMSNs) to construct… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

He, Q., Zhou, L., Yu, D., Zhu, R., Chen, Y., Song, M., Liu, X., Liao, Y., Ding, T., Fan, W., & Yu, W. (2023). Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy. Journal of Medicinal Chemistry, 66(15), 10458–10472. https://doi.org/10.1021/acs.jmedchem.3c00587

MLA 9

He, Qi, et al. “Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy.” Journal of Medicinal Chemistry, vol. 66, no. 15, 2023, pp. 10458–10472. https://doi.org/10.1021/acs.jmedchem.3c00587.

Chicago

He, Qi, Liming Zhou, D.P. Yu, Ren Zhu, Yue Chen, Mingbo Song, Xintong Liu, et al. 2023. “Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy.” Journal of Medicinal Chemistry 66 (15): 10458–10472. https://doi.org/10.1021/acs.jmedchem.3c00587.

Harvard

He, Q. et al. (2023) ‘Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy’, Journal of Medicinal Chemistry, 66(15), pp. 10458–10472. doi:10.1021/acs.jmedchem.3c00587.

IEEE

Q. He et al., “Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy,” Journal of Medicinal Chemistry, vol. 66, no. 15, pp. 10458–10472, 2023, doi: 10.1021/acs.jmedchem.3c00587.

BibTeX

@article{he2023near,
  title     = {{Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy}},
  author    = {He, Qi and Zhou, Liming and Yu, D.P. and Zhu, Ren and Chen, Yue and Song, Mingbo and Liu, Xintong and Liao, Yixian and Ding, Tong and Fan, Wenpei and Yu, Wenying},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2023},
  volume    = {66},
  number    = {15},
  pages     = {10458--10472},
  doi       = {10.1021/acs.jmedchem.3c00587},
  url       = {https://doi.org/10.1021/acs.jmedchem.3c00587}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202355
20241616
20252727
20264040

Its field-weighted citation impact is 6.18: it has been cited 6.18 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • PROTACs
  • near-infrared light activation
  • nanocages
  • mesoporous silica nanoparticles
  • upconversion nanoparticles
  • BRD4 degradation
  • targeted protein degradation
  • tumor growth inhibition

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

He, Q., Zhou, L., Yu, D., Zhu, R., Chen, Y., Song, M., Liu, X., Liao, Y., Ding, T., Fan, W., & Yu, W. (2023). Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy. Journal of Medicinal Chemistry, 66(15), 10458–10472. https://doi.org/10.1021/acs.jmedchem.3c00587

How many times has this paper been cited?

88 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Qi He, Liming Zhou, D.P. Yu, Ren Zhu, Yue Chen, Mingbo Song, Xintong Liu, Yixian Liao, Tong Ding, Wenpei Fan, Wenying Yu.

What is the DOI of this paper?

10.1021/acs.jmedchem.3c00587, permanently at https://doi.org/10.1021/acs.jmedchem.3c00587. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.